NCCN Pharmacy Updates: New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm
Join Emily K. Dotson, PharmD, BCOP, from The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute for this webinar in the 2018 NCCN Pharmacy Update Series on the topic New Therapies for Chronic Lymphocytic Leukemia and a Changing Treatment Paradigm.
This educational program is designed to meet the educational needs of pharmacists, nurses, nurse practitioners, physician assistants, and other health care professionals who manage patients with cancer.
Following this activity, participants should be able to:
- Review the mechanism of action and therapeutic uses of novel agents for the treatment of CLL/SLL.
- Describe the dosing, monitoring and special considerations associated with the novel therapeutic agents for CLL/SLL.
- Identify strategies for prophylaxis and prevention of viral reactivation and opportunistic infections in patients with CLL/SLL.
Emily K. Dotson, PharmD, BCOP
The Ohio State University Comprehensive Cancer Center -
James Cancer Hospital and Solove Research Institute
Disclosure of Relevant Financial Relationships
All faculty and activity planners participating in NCCN continuing education activities are expected to disclose any relevant financial relationships with a commercial interest as defined by the ACCME’s, ANCC’s, and ACPE’s Standards for Commercial Support. All faculty presentations have been reviewed for adherence to the ACCME’s Criterion 7: The provider develops activities/educational interventions independent of commercial interests (SCS 1, 2, and 6) by experts on the topics. Full disclosure of faculty relationships will be made prior to the activity.
National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
NCCN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. PAs may receive a maximum of 1.0 hour of Category 1 credit for completing this activity.
National Comprehensive Cancer Network (NCCN) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
NCCN designates this educational activity for a maximum of 1.0 contact hour.
|National Comprehensive Cancer Network (NCCN) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.|
NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.1 CEUs) of continuing education credit. UAN: 0836-0000-18-138-L01-P
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 Participation
Click the Take Course button to register for this upcoming live webinar.
This webinar will be presented live one time only on Tuesday, November 27, 2018, from 12:30 - 1:30 PM Eastern Standard Time (EST) (UTC -5). To convert the start time of this webinar for other time zones, click here.
To complete this activity, users will need:
- A device with an Internet connection and sound playback capability
- One of the two latest versions of Google Chrome, Mozilla Firefox, or Safari
- Internet Explorer is no longer supported
- Adobe Reader or other PDF reader software for certificate viewing/printing